CLINICAL AND VIROLOGIC RESPONSES TO A RECOMBINANT VACCINIA HIV-1 GP160 VACCINE (HIVAC-1E)

被引：0
|
作者：
COREY, L
COLLIER, A
COOMBS, R
ARDITTI, D
HU, SL
GREENBERG, P
MCLAREN, C
MARTIN, R
DRAGAVON, J
CHALOUPKA, K
机构：
[1] UNIV WASHINGTON,SEATTLE,WA 98195
[2] BRISTOL MYERS CORP,WALLINGFORD,CT
来源：
CLINICAL RESEARCH | 1989年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A562 / A562
页数：1
相关论文
共 50 条
  • [41] Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site
    Oliva, R
    Leone, M
    Falcigno, L
    D'Auria, G
    Dettin, M
    Scarinci, C
    Di Bello, C
    Paolillo, L
    [J]. CHEMISTRY-A EUROPEAN JOURNAL, 2002, 8 (06) : 1467 - 1473
  • [42] Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses
    Megati, Shakuntala
    Garcia-Hand, Dorys
    Cappello, Sarah
    Roopchand, Vidia
    Masood, Amjed
    Xu, Rong
    Luckay, Amara
    Chong, Siew-Yen
    Rosati, Margherita
    Sackitey, Solomon
    Weiner, David B.
    Felber, Barbara K.
    Pavlakis, George N.
    Israel, Zimra R.
    Smith, Larry R.
    Eldridge, John H.
    Sidhu, Maninder K.
    Egan, Michael A.
    [J]. VACCINE, 2008, 26 (40) : 5083 - 5094
  • [43] The extracellular processing of HIV-1 envelope glycoprotein gp160 by human plasmin
    Okumura, Y
    Yano, M
    Murakami, M
    Mori, S
    Towatari, T
    Kido, H
    [J]. FEBS LETTERS, 1999, 442 (01) : 39 - 42
  • [44] IMMUNOGENICITY OF BACULOVIRUS DERIVED HIV-1 GP160 IN INBRED STRAINS OF MICE
    KENNEDY, RC
    WARREN, RQ
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 80 - 80
  • [45] CHARACTERIZATION OF A SOLUBLE, OLIGOMERIC HIV-1 GP160 PROTEIN AS A POTENTIAL IMMUNOGEN
    VANCOTT, TC
    VEIT, SCD
    KALYANARAMAN, V
    EARL, P
    BIRX, DL
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 183 (01) : 103 - 117
  • [46] ANTI-HIV-1 VACCINE CLINICAL-TRIAL PHASE-1 USING GP160 AS ANTIGEN
    PICARD, O
    ZAGURY, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 681 - 681
  • [47] Characterization and enhancement of the interaction between HIV-1 gp120/gp160 and MBL
    Hart, ML
    Saifuddin, M
    Spear, GT
    [J]. FASEB JOURNAL, 2001, 15 (04): : A691 - A691
  • [48] ANTIBODY FINE SPECIFICITY TO HIV-1 GP160 EPITOPES IN GROUPS OF HIV-1 INFECTED INDIVIDUALS AND CORRELATION WITH CLINICAL-DISEASE PROGRESSION
    WONG, MT
    WARREN, RQ
    ANDERSON, SA
    DOLAN, MJ
    MELCHER, GP
    BOSWELL, RN
    KENNEDY, RC
    [J]. JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A241 - A241
  • [49] EFFECTS OF ADJUVANTS AND MULTIPLE ANTIGEN PEPTIDES ON HUMORAL AND CELLULAR IMMUNE-RESPONSES TO GP160 OF HIV-1
    LEVI, M
    RUDEN, U
    BIRX, D
    LOOMIS, L
    REDFIELD, R
    LOVGREN, K
    AKERBLOM, L
    SANDSTROM, E
    WAHREN, B
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (08): : 855 - 864
  • [50] AN HIV-1 GP160-RECOMBINANT VACCINIA VIRUS-VACCINE INDUCES HIV-1-SPECIFIC CD8+ HUMAN CYTOTOXIC T LYMPHOCYTES
    HAMMOND, SA
    BOLLINGER, RC
    CLEMENTS, ML
    SILICIANO, RF
    [J]. FASEB JOURNAL, 1992, 6 (05): : A1725 - A1725
12345